Connection

JOYA CHANDRA to Glioblastoma

This is a "connection" page, showing publications JOYA CHANDRA has written about Glioblastoma.
Connection Strength

0.847
  1. Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo. Sci Rep. 2016 Jan 25; 6:18953.
    View in: PubMed
    Score: 0.247
  2. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol. 2015 Nov; 17(11):1463-73.
    View in: PubMed
    Score: 0.233
  3. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro Oncol. 2011 Aug; 13(8):894-903.
    View in: PubMed
    Score: 0.179
  4. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1. Cancer Chemother Pharmacol. 2007 Mar; 59(4):527-35.
    View in: PubMed
    Score: 0.128
  5. A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies. Oncotarget. 2015 Sep 15; 6(27):23631-46.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.